Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First in Human Study to Assess Safety and Performance of the DaVingi™ System in the Treatment of Patients With Functional Tricuspid Regurgitation

NCT03700918 is registered in ClinicalTrials.gov with Cardiac Implants LLC as lead sponsor.

NCT NCT03700918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03700918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First in Human Study to Assess Safety and Performance of the DaVingi™ System in the Treatment of Patients With Functional Tricuspid Regurgitation
Lead sponsor
Cardiac Implants LLC
Phase
Not applicable
Overall status
Unknown status
Start date
November 11, 2017
Completion date
June 30, 2022
Enrollment
15 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

functional tricuspid regurgitation (tr)